Department of Internal Medicine

Gastroenterology-Hepatology Faculty


Michael Voigt photo

Medical School:
Pretoria University, South Africa
University of Cape Town, S Africa

Residency:
Groote Schuur Hospital

Fellowship:
Groote Schuur Hospital

Michael D. Voigt, M.D.
Clinical Professor

Dr. Voigt is interested in diseases of the liver, with special interest in liver transplantation. His areas of research interest include autonomic function in portal hypertension and its effects on hemodynamics, pulmonary vascular and renal function. He is Medical Director of Liver Failure and Transplantation.

Dr. Voigt is particularly interested in liver transplantation, Liver failure and portal hypertension.

Honors, Awards, and Organizations

Recent Publications

  1. Chalasani N, Manzarbeitia C, Ferenci P, Vogel W, Fontana RJ, Voigt M, Riely C, Martin P, Teperman L, Jiao J, Lopez-Talavera JC. Peginterferon alfa-2a for hepatitis C after liver transplantation: Two randomized, controlled trials. Hepatology. 2005 Feb;41(2):289-298.
  2. Voigt, MD. Alcohol in hepatocellular cancer. Clin Liver Dis. 2005 Feb;9(1):151-169. PMID:15763234.
  3. Rayhill SC, Kirby PA, Voigt MD, LaBrecque DR, Lutz CT, Katz DA, Mitros FA, Kalil RS, Miller RA, Stolpen AH, Heisey D, Wu YM, Schmidt WN. Positive serum cryoglobulin is associated with worse outcome after liver transplantation for chronic hepatitis C. Transplantation. 2008 Aug 27;80(4):448-456. PMID:16123717.
  4. McGuire BM, Bonkovsky HL, Carithers RL Jr, Chung RT, Goldstein LI, Lake JR, Lok AS, Potter CJ, R Rand E, Voigt MD, Davis PR, Bloomer JR. Liver transplantation for erythropoietic protoporphyria liver disease. Liver Transplantation. 2005 Dec;11(12):1590-1596. PMID:16315313.
  5. Sulieman BM, Hunsicker LG, Katz DA, Voigt MD. OPTN Policy regarding prioritization of patients with hepatopulmonary syndrome: does it provide equitable organ allocation? American Journal of Transplantation. 2008;8(5):955- (in press)

Links of Interest

Back to Gastroenterology-Hepatology Faculty List